Attending
VitaCyte will attend the 18th Congress of the International Xenotransplantation Association 2025 in Geneva Switzerland from September 30 to October 3, 2025. Drew Breite and Bob McCarthy will attend the meeting and present posters at the Welcome Reception/Poster Session 1 on “An ancillary material supplier’s perspective on ISO 20399:2022” and “A rational design method for tissue dissociation enzyme optimization.” The latter presentation applies the concepts from VitaCyte’s model of enzyme-mediated tissue dissociation to simplify optimization of enzyme formulations. Both will be available to discuss technical questions related to the portfolio of VitaCyte products designed for xenotransplantation. Look for them at the meeting or reach out directly to set up a time to meet!
Andrew Breite
Director of Quality Assurance
Bob McCarthy
President & Co-Founder